Arbutus Biopharma Corporation ABUS
3.66 USD -0.02 (-0.41%)
At closeNov 6, 2026, 4:50 PM EST
3.65 0.00 -0.14%
After hours · Nov 6, 4:50 PM ET
3.63 Day range 3.75
3.50 52-week range 5.45
- YTD
- -24.01%
- 1 year
- -17.68%
News
benzinga.com FDA Lifts Three-Year Freeze On Arbutus Biopharma's Hepatitis B Study The FDA lifts its 3-year clinical hold on Arbutus Biopharma's AB-101 hepatitis B drug candidate, clearing US clinical trials.
benzinga.com Arbutus Biopharma Says FDA Lifts Clinical Hold On AB-101 IND, Company May Now Engage In Additional Clinical Development For AB-101 In US Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that the Company was notified by the
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Why Is Arbutus Biopharma Stock Gaining Friday? Arbutus Biopharma (ABUS) stock rises after announcing a $230M stock buyback via a modified Dutch auction. Get the offer details.
benzinga.com Arbutus Biopharma Plans To Commence Modified Dutch Auction Tender Offer To Repurchase Up To $230M Of Common Shares At Purchase Price Of Between $5.00 And $5.75 Per Share In Cash Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified "Dutch
benzinga.com Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K Estimate Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 400 percent decrease over earnings of…- benzinga.com Arbutus Biopharma Announces Filing Of Three International Lawsuits Seeking To Enforce Patents Protecting LNP Technology Against Pfizer, BioNTech And Certain Of Their Affiliates Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle ("LNP") technology against Pfizer and…
- benzinga.com Arbutus Biopharma Q1 EPS $0.87 Beats $(0.04) Estimate, Sales $179.126M Beat $750.000K Estimate Arbutus Biopharma (NASDAQ:ABUS) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $(0.04) by 2275 percent. This is a 769.23 percent increase over losses of…
benzinga.com Europe Clears First Flu/COVID Combo Shot From Moderna Moderna stock rises after EU approval of flu-COVID combo vaccine mCOMBRIAX, backed by Phase 3 data showing strong immune response.
benzinga.com QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopharma among other stocks also falling.
benzinga.com Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket J B Hunt Transport Services Inc (JBHT) stock rose in pre-market trading after beating earnings estimates. Gainers include CTNT, MYSE, WNW, MDCX, WSHP, MAMO, ALIT, HQ, and SLDP while XHG and BIRD were…- benzinga.com Arbutus Biopharma's Imdusiran Receives FDA's Fast Track Designation To Treat Chronic Hepatitis B Arbutus Biopharma Corporation (Nasdaq: ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that the U.S. Food and Drug…
benzinga.com Arbutus Biopharma Q4 EPS $(0.01) Beats $(0.03) Estimate, Sales $1.051M Miss $1.233M Estimate Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 85.71 percent increase over losses of…
benzinga.com Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor concerns and clearing legal uncertainty.
benzinga.com Staar Surgical Posts Downbeat Q4 Results, Joins Webtoon Entertainment, Gitlab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com Why Box Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket Box Inc (BOX) shares jump 6.2% in pre-market trading after beating earnings expectations with $305.88M in revenue and 49 cents per share earnings.- benzinga.com Roivant Sciences' Subsidiary, Arbutus Biopharma Sign $2.25B Settlement With Moderna To Resolve All U.S., Global Enforcement Actions; Moderna To Pay $950M Upfront Payment To Genevant, Arbutus Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio and a subsidiary of Roivant Sciences Ltd. (NASDAQ:ROIV),…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
benzinga.com Arbutus Biopharma Q3 EPS $(0.04) Misses $(0.03) Estimate, Sales $529.000K Miss $1.267M Estimate Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 60 percent increase over losses of…- benzinga.com Walmart To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com Earnings Scheduled For February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.- benzinga.com Earnings Scheduled For May 4, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
benzinga.com Earnings Scheduled For March 2, 2023 Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.- benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
benzinga.com Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate Here's a roundup of top developments in the biotech space over the last 24 hours:- benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
- benzinga.com Earnings Scheduled For May 5, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.
- benzinga.com Earnings Scheduled For March 3, 2022 Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
- benzinga.com Mid-Morning Market Update: Markets Open Higher; G-III Apparel Earnings Beat Views Following the market opening Wednesday, the Dow traded up 0.99% to 34,824.47 while the NASDAQ climbed 1.40% to 15,755.57. The S&P also rose, gaining 1.39% to 4,630.57.
- benzinga.com The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week.
- benzinga.com Earnings Scheduled For November 4, 2021 Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
- benzinga.com 60 Biggest Movers From Friday Gainers
- benzinga.com 41 Stocks Moving In Friday's Mid-Day Session Gainers
- benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
- benzinga.com 28 Stocks Moving in Friday's Pre-Market Session Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales.
- benzinga.com Earnings Scheduled For May 5, 2021 Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For March 4, 2021 Companies Reporting Before The Bell • Toro (NYSE:TTC) is expected to report quarterly earnings at $0.75 per share on revenue of $851.38 million.
benzinga.com Earnings Scheduled For November 5, 2020 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.- benzinga.com 60 Biggest Movers From Yesterday Gainers
- benzinga.com 42 Stocks Moving In Tuesday's Mid-Day Session Gainers
- benzinga.com Earnings Scheduled For August 7, 2020 Companies Reporting Before The Bell • Canadian Solar Inc. (NASDAQ:CSIQ) is expected to report quarterly loss at $0.04 per share on revenue of $662.95 million.
- benzinga.com 31 Stocks Moving in Monday's Pre-Market Session Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares rose 184% to $10.41 in pre-market trading after gaining around 6% on Friday.
- benzinga.com 68 Biggest Movers From Friday Gainers Ascena Retail Group, Inc. (NASDAQ: ASNA) shares surged 119.8% to close at $1.29 on Friday. Ascena Retail shares dipped 26% on Thursday after the company filed voluntary Chapter 11 petitions.
- benzinga.com 51 Stocks Moving In Friday's Mid-Day Session Gainers
- benzinga.com Stocks That Hit 52-Week Highs On Friday During Friday's morning session, 28 stocks hit new 52-week highs.
- benzinga.com 55 Biggest Movers From Yesterday